Tag Archives: recurrence

Tracking Mesothelioma Recurrence: FDG-PET/CT Versus CT

mesothelioma recurrence

FDG-PET/CT may be a more effective way to track malignant pleural mesothelioma recurrence than contrast-enhanced CT scanning.  That is the conclusion of cancer researchers with Japan’s Hyogo College of Medicine. The researchers focused on fifty patients who underwent radical surgery for pleural mesothelioma. Afterwards, doctors used both FDG-PET/CT and contrast-enhanced CT scans to track mesothelioma progression. Two experienced examiners assessed the cases. They concluded that FDG-PET/CT was more accurate than CT for diagnosing mesothelioma recurrence. Mesothelioma Recurrence After Surgery Pleural mesothelioma is one of the most difficult cancers to treat. It arises in the layers of the pleural membrane that surrounds the lungs. Mesothelioma tumors tend to grow and spread quickly. Treatments like chemotherapy, surgery, and radiotherapy can sometimes slow … Continue reading Tracking Mesothelioma Recurrence: FDG-PET/CT Versus CT »

Conservative Surgery Leads to Better Mesothelioma Survival After Recurrence

mesothelioma survival

Mesothelioma survival after recurrence may be better with lung-preserving P/D surgery than with more radical EPP. Japanese researchers recently analyzed the cases of 44 mesothelioma patients who underwent either EPP or P/D. It took about the same amount of time for mesothelioma tumors to start growing again, no matter what type of surgery the patient had. The difference was in survival. Both overall survival and mesothelioma survival after recurrence were longer in the P/D patients. EPP vs. P/D: The Ongoing Debate Mesothelioma surgeons around the world are still divided about which type of mesothelioma surgery is best. On one hand, extrapleural pneumonectomy (EPP) removes more diseased tissue, including a lung. Some say this improves the odds of long term mesothelioma … Continue reading Conservative Surgery Leads to Better Mesothelioma Survival After Recurrence »

Avelumab May Offer a Second-Line Option for Recurrent Mesothelioma

recurrent mesothelioma treatment

People with recurrent mesothelioma may get another chance at treatment with the immunotherapy drug avelumab. Malignant mesothelioma is highly resistant to standard cancer therapies. That means that the asbestos cancer usually comes back, or recurs, even after treatment. The most common treatment for mesothelioma is chemotherapy with Alimta. Alimta is the only drug approved specifically for mesothelioma. Patients with recurrent mesothelioma often have several rounds of chemotherapy with Alimta. But once the standard mesothelioma treatments stop working, patients do not have many options. Now a new study suggests that some cases of recurrent mesothelioma that stop responding to Alimta may respond to avelumab.   Considering Avelumab for Recurrent Mesothelioma Bavencio is the brand name for avelumab. It is a type … Continue reading Avelumab May Offer a Second-Line Option for Recurrent Mesothelioma »